CBP501 / CanBas 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CBP501 / CanBas
NCT04953962: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer

Completed
2
36
US
CBP501 (16), CBP501, CBP501 (25), Cisplatin, CDDP, Nivolumab, Opdivo
CanBas Co. Ltd.
Pancreatic Cancer Stage IV
04/23
04/23

Download Options